Safety of hepatitis-B vaccines containing intact 20 nm particles.
作者信息
Trepo C, Prince A M, Meliconi R, Eddlestone A L, Williams R, Tage-Jensen U, Nielsen J O
出版信息
Lancet. 1979 Mar 3;1(8114):488. doi: 10.1016/s0140-6736(79)90836-5.
PMID:85067
Abstract
摘要
相似文献
1
Safety of hepatitis-B vaccines containing intact 20 nm particles.
Lancet. 1979 Mar 3;1(8114):488. doi: 10.1016/s0140-6736(79)90836-5.
2
Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
J Med Primatol. 1984;13(3):119-33.
3
[Vaccination against viral hepatitis].
ZFA (Stuttgart). 1984 Jan 10;60(1):4-9.
4
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174-8. doi: 10.1073/pnas.83.23.9174.
5
[Hepatitis B vaccine: results of the Belgian clinical trials with 150 volunteers].
Rev Med Liege. 1982 Apr 15;37(8):261-7.
6
Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
J Infect Dis. 1983 Feb;147(2):327-35. doi: 10.1093/infdis/147.2.327.
7
Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
J Med Virol. 1981;6(4):279-84. doi: 10.1002/jmv.1890060403.
8
Hepatitis-B vaccine. Safety criteria and non-B infection.
Lancet. 1976 Jun 26;1(7974):1396-7. doi: 10.1016/s0140-6736(76)93039-7.
9
[What should a vaccine against hepatitis B be like?].
Vopr Virusol. 1978 Nov-Dec(6):643-9.
10
[Viral hepatitis B vaccine].
Clin Ter. 1983 Mar 31;104(6):483-93.
引用本文的文献
1
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
Proc Natl Acad Sci U S A. 1982 Jan;79(2):579-82. doi: 10.1073/pnas.79.2.579.
Zotero 插件